FR2419729A1 - METHOD OF MANUFACTURING SOLID PREPARATIONS CONTAINING GEFARNATE - Google Patents
METHOD OF MANUFACTURING SOLID PREPARATIONS CONTAINING GEFARNATEInfo
- Publication number
- FR2419729A1 FR2419729A1 FR7906384A FR7906384A FR2419729A1 FR 2419729 A1 FR2419729 A1 FR 2419729A1 FR 7906384 A FR7906384 A FR 7906384A FR 7906384 A FR7906384 A FR 7906384A FR 2419729 A1 FR2419729 A1 FR 2419729A1
- Authority
- FR
- France
- Prior art keywords
- gefarnate
- preparations containing
- solid preparations
- manufacturing solid
- pka
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Le procédé consiste à faire absorber le Gefarnate dans une base solide qui peut être un silicate, l'oxyde de magnésium, un gel sec d'hydroxyde d'aluminium, etc, dont la surface a été traitée au préalable par un agent d'ajustement tel que l'acide citrique, l'alcool polyvinylique, la gomme arabique, etc., de façon à maintenir son pKa à 9,3 ou moins. Ce procédé est basé sur la découverte du fait que la décomposition du Gefarnate est favorisée lorsque le pKa de la surface est supérieur à 9,3. Le procédé permet d'obtenir une composition médicinale de Gefanate qui est très stable à la conservation.The process consists of absorbing the Gefarnate in a solid base which can be a silicate, magnesium oxide, a dry gel of aluminum hydroxide, etc., the surface of which has been previously treated with an adjusting agent. such as citric acid, polyvinyl alcohol, gum arabic, etc., so as to keep its pKa at 9.3 or less. This method is based on the discovery that the decomposition of Gefarnate is promoted when the pKa of the surface is greater than 9.3. The process results in a medicinal composition of Gefanate which is very stable on storage.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP53029746A JPS6026093B2 (en) | 1978-03-14 | 1978-03-14 | Method for producing gefalnate-containing solid preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2419729A1 true FR2419729A1 (en) | 1979-10-12 |
FR2419729B1 FR2419729B1 (en) | 1988-07-08 |
Family
ID=12284653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7906384A Expired FR2419729B1 (en) | 1978-03-14 | 1979-03-13 | PROCESS FOR PRODUCING SOLID PREPARATIONS CONTAINING GEFARNATE |
Country Status (17)
Country | Link |
---|---|
JP (1) | JPS6026093B2 (en) |
AR (1) | AR218711A1 (en) |
BE (1) | BE874795A (en) |
CH (1) | CH637827A5 (en) |
CS (1) | CS207784B2 (en) |
ES (1) | ES478539A0 (en) |
FR (1) | FR2419729B1 (en) |
GB (1) | GB2016271B (en) |
HK (1) | HK49283A (en) |
IE (1) | IE48269B1 (en) |
IT (1) | IT1162282B (en) |
MT (1) | MTP843B (en) |
MX (1) | MX5996E (en) |
NL (1) | NL7901917A (en) |
PH (1) | PH16903A (en) |
PT (1) | PT69341A (en) |
ZA (1) | ZA791103B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3320583A1 (en) * | 1983-06-08 | 1984-12-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | NEW GALENIC PREPARATION FORMS OF ORAL ANTIDIABETICS AND METHOD FOR THE PRODUCTION THEREOF |
ES2055894T3 (en) * | 1989-04-07 | 1994-09-01 | Ciba Geigy Ag | CONCENTRATES OF PESTICIDED ACTIVE SUBSTANCES AND THEIR PREPARATION. |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1467976A1 (en) * | 1963-09-18 | 1969-01-16 | Key Pharma | Carriers for pharmaceuticals and processes for their manufacture |
JPS50126821A (en) * | 1974-02-14 | 1975-10-06 | ||
LU76238A1 (en) * | 1976-06-29 | 1977-05-23 | ||
JPS53148519A (en) * | 1977-05-31 | 1978-12-25 | Sumitomo Chem Co Ltd | Preparation of solid medicine containing gefarnate |
-
1978
- 1978-03-14 JP JP53029746A patent/JPS6026093B2/en not_active Expired
- 1978-08-25 PH PH21668A patent/PH16903A/en unknown
-
1979
- 1979-03-09 ZA ZA791103A patent/ZA791103B/en unknown
- 1979-03-09 NL NL7901917A patent/NL7901917A/en not_active Application Discontinuation
- 1979-03-09 AR AR275761D patent/AR218711A1/en active
- 1979-03-12 ES ES478539A patent/ES478539A0/en active Granted
- 1979-03-13 FR FR7906384A patent/FR2419729B1/en not_active Expired
- 1979-03-13 MX MX797810U patent/MX5996E/en unknown
- 1979-03-13 PT PT69341A patent/PT69341A/en unknown
- 1979-03-13 MT MT843A patent/MTP843B/en unknown
- 1979-03-13 IT IT48332/79A patent/IT1162282B/en active
- 1979-03-13 BE BE0/193985A patent/BE874795A/en not_active IP Right Cessation
- 1979-03-13 GB GB7908723A patent/GB2016271B/en not_active Expired
- 1979-03-13 CS CS791652A patent/CS207784B2/en unknown
- 1979-03-14 CH CH243379A patent/CH637827A5/en not_active IP Right Cessation
- 1979-08-08 IE IE725/79A patent/IE48269B1/en not_active IP Right Cessation
-
1983
- 1983-11-03 HK HK492/83A patent/HK49283A/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1467976A1 (en) * | 1963-09-18 | 1969-01-16 | Key Pharma | Carriers for pharmaceuticals and processes for their manufacture |
JPS50126821A (en) * | 1974-02-14 | 1975-10-06 | ||
LU76238A1 (en) * | 1976-06-29 | 1977-05-23 | ||
JPS53148519A (en) * | 1977-05-31 | 1978-12-25 | Sumitomo Chem Co Ltd | Preparation of solid medicine containing gefarnate |
Non-Patent Citations (3)
Title |
---|
CA1976 * |
CA1978 * |
DW1979 * |
Also Published As
Publication number | Publication date |
---|---|
CS207784B2 (en) | 1981-08-31 |
ES8200632A1 (en) | 1981-11-01 |
PH16903A (en) | 1984-04-10 |
JPS54122718A (en) | 1979-09-22 |
FR2419729B1 (en) | 1988-07-08 |
NL7901917A (en) | 1979-09-18 |
ES478539A0 (en) | 1981-11-01 |
AR218711A1 (en) | 1980-06-30 |
ZA791103B (en) | 1980-03-26 |
HK49283A (en) | 1983-11-11 |
CH637827A5 (en) | 1983-08-31 |
MX5996E (en) | 1984-09-18 |
GB2016271B (en) | 1982-09-02 |
IT1162282B (en) | 1987-03-25 |
MTP843B (en) | 1980-02-11 |
GB2016271A (en) | 1979-09-26 |
BE874795A (en) | 1979-07-02 |
IE790725L (en) | 1979-09-14 |
JPS6026093B2 (en) | 1985-06-21 |
PT69341A (en) | 1979-04-01 |
IE48269B1 (en) | 1984-11-28 |
IT7948332A0 (en) | 1979-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU589841B2 (en) | Skin treatment composition | |
IL56592A (en) | Microcapsules of polyvinyl alcohol with liquid,water-insoluble content and process for their manufacture | |
FR2419729A1 (en) | METHOD OF MANUFACTURING SOLID PREPARATIONS CONTAINING GEFARNATE | |
EP0355368A3 (en) | A cleansing-agent composition and its use | |
FR1572794A (en) | ||
FR2295753A1 (en) | Topical acetylsalicylic acid compsns. - contg. as vehicle an inert, hydrophilic lipophilic penetrant | |
IT1065691B (en) | PROCESS FOR THE PREPARATION OF FILMS AND COATINGS CONTAINING POLYVINYL ALCOHOL WITH DECREASED WATER SOLUBILITY | |
IT1042809B (en) | PROCEDURE FOR THE MANUFACTURE OF METHACRYLIC ACID AND OXIDATION CATALYST TO BE USED IN SUCH PROCEDURE | |
SU734252A1 (en) | Method of fermentation and storage of rose flowers prior to their hydrodistillation | |
JPS5526686A (en) | Manufacturing semiconductor device | |
JPS5229561A (en) | Welded nut and its manufacturing process | |
JPS5260080A (en) | Semiconductor device | |
Dai et al. | CLS and AES Studies of Oxygen Adsorption and Initial Oxidation on Clean Indium Surface | |
JPS5246018A (en) | Process for preparation of farnesyl acetates | |
JPS52144972A (en) | Formation method of photo resist film | |
FR1292447A (en) | Method for preventing the formation of acetic aldehyde in the solution containing vinyl acetate and alcohol | |
JPS5543023A (en) | Prevention of damage of bordeaux mixture to citrus fruit | |
SU1192274A1 (en) | METHOD FOR PRODUCING HYDROGEN | |
JPS5222588A (en) | Production process of filter medium for collecting heavy metals | |
Howe | Infrared studies of gas absorption on germanium. | |
JPS5337594A (en) | Production of active carbon | |
Guennou et al. | Secondary Electron Spectra From Solid Samples of Aluminum and Magnesium | |
IT7841620A0 (en) | CONTEMPORARY SEPARATION OF THE CONCENTRATION PROCESS AND SUSPENDED SUBSTANCES OF AQUEOUS SOLUTIONS-SUSPENSIONS WITH HIGH ORGANIC SUBSTANCE CONTENT BY CRYOGENIC METHOD. | |
JPS5227735A (en) | Process for preparation of brominated diphenylethers having sability t o light | |
BE829833A (en) | FILLIFORM ABRASIVE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transmission of property | ||
TP | Transmission of property | ||
ST | Notification of lapse |